274 related articles for article (PubMed ID: 22571571)
1. TNF-α inhibitor (adalimumab) induced psoriasis: a case report.
Al-Mutairi A; Elkashlan M; Al-Fayed HM; Swayed M
Australas J Dermatol; 2012 May; 53(2):157. PubMed ID: 22571571
[No Abstract] [Full Text] [Related]
2. Adalimumab-induced psoriasis in a patient with Crohn's disease.
Korkmaz U; Duman AE; Dindar G; Yilmaz H; Dursun IH; Celebi A; Senturk O; Hulagu S
Indian J Gastroenterol; 2013 Mar; 32(2):135-6. PubMed ID: 23151897
[No Abstract] [Full Text] [Related]
3. First case report of adalimumab-induced psoriasis in Crohn's disease.
Harris MD; Richards R
Am J Gastroenterol; 2009 Mar; 104(3):792-3. PubMed ID: 19262532
[No Abstract] [Full Text] [Related]
4. [Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].
Sansó Sureda A; Rocamora Durán V; Sapiña Camaró A; Royo Escosa V; Bosque López MJ
Gastroenterol Hepatol; 2011 Oct; 34(8):546-50. PubMed ID: 21665330
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature.
Cullen G; Kroshinsky D; Cheifetz AS; Korzenik JR
Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1318-27. PubMed ID: 21957906
[TBL] [Abstract][Full Text] [Related]
6. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
[TBL] [Abstract][Full Text] [Related]
7. Psoriasiform dermatitis in a non-psoriatic patient treated with adalimumab.
Tammaro A; Persechino S; Abruzzese C; Narcisi A; Cortesi G; Parisella FR; Laganà B
Int J Immunopathol Pharmacol; 2012; 25(2):499-501. PubMed ID: 22697082
[TBL] [Abstract][Full Text] [Related]
8. [Infliximab-induced pustular psoriasis in a patient with Crohn's disease].
Monteagudo Sánchez B; Cabanillas M; Ortiz-Marin S; Gallego-Ojea JC
Gastroenterol Hepatol; 2009 Mar; 32(3):175-6. PubMed ID: 19233516
[No Abstract] [Full Text] [Related]
9. Generalized pustular psoriasis-like eruptions induced after the first use of adalimumab in the treatment of psoriatic arthritis.
Kimura U; Kinoshita A; Haruna K; Mizuno Y; Sekigawa I; Takamori K; Suga Y
J Dermatol; 2012 Mar; 39(3):286-7. PubMed ID: 21957978
[No Abstract] [Full Text] [Related]
10. New-onset psoriasis associated with adalimumab: a report of two cases.
Glenn CJ; Kobraei KB; Russo JJ
Dermatol Online J; 2011 Sep; 17(9):15. PubMed ID: 21971280
[TBL] [Abstract][Full Text] [Related]
11. Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: case report and review.
Puig L; Morales-Múnera CE; López-Ferrer A; Geli C
Dermatology; 2012; 225(1):14-7. PubMed ID: 22890275
[TBL] [Abstract][Full Text] [Related]
12. Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: report of five cases and review of the literature.
Osório F; Magro F; Lisboa C; Lopes S; Macedo G; Bettencourt H; Azevedo F; Magina S
Dermatology; 2012; 225(2):163-7. PubMed ID: 23052429
[TBL] [Abstract][Full Text] [Related]
13. Pityriasis amiantacea: a distinctive presentation of psoriasis associated with tumour necrosis factor-α inhibitor therapy.
Ettler J; Wetter DA; Pittelkow MR
Clin Exp Dermatol; 2012 Aug; 37(6):639-41. PubMed ID: 22300412
[TBL] [Abstract][Full Text] [Related]
14. Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis.
Marcella S; Welsh B; Foley P
Australas J Dermatol; 2011 Aug; 52(3):e8-11. PubMed ID: 21834808
[TBL] [Abstract][Full Text] [Related]
15. Palmoplantar pustulosis with fulminant dystrophic 20-nail psoriasis in a patient receiving adalimumab therapy.
Mishra V; Daniel RC; Elmets CA; Levin A; Elewski BE
J Drugs Dermatol; 2013 Jan; 12(1):16-7. PubMed ID: 23377322
[No Abstract] [Full Text] [Related]
16. [Level of adalimumab and its antibody titers define the effectiveness of the biological (anticytokine) therapy in Crohn's disease].
Lazebnik LB; Sagynbaeva VÉ
Eksp Klin Gastroenterol; 2013; (7):18-22. PubMed ID: 24772870
[TBL] [Abstract][Full Text] [Related]
17. [Flexural psoriasis induced by infliximab and adalimumab in a patient with Crohn's disease].
Avila Alvarez A; García-Alonso L; Solar Boga A; García-Silva J
An Pediatr (Barc); 2009 Mar; 70(3):278-81. PubMed ID: 19409245
[TBL] [Abstract][Full Text] [Related]
18. Five cases of anti-tumor necrosis factor alpha-induced psoriasis presenting with severe scalp involvement in children.
Perman MJ; Lovell DJ; Denson LA; Farrell MK; Lucky AW
Pediatr Dermatol; 2012; 29(4):454-9. PubMed ID: 21995665
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE.
Ortonne JP; Chimenti S; Reich K; Gniadecki R; Sprøgel P; Unnebrink K; Kupper H; Goldblum O; Thaçi D
J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1012-20. PubMed ID: 21214631
[TBL] [Abstract][Full Text] [Related]
20. Palmoplantar pustulosis by adalimumab in a patient with Crohn disease.
Ortiz Salvador JM; Cubells Sánchez L; Subiabre Ferrer D
Med Clin (Barc); 2016 Dec; 147(12):565. PubMed ID: 27431884
[No Abstract] [Full Text] [Related]
[Next] [New Search]